A AMERIGEN PHARMACEUTICALS

What this means for you

This application is over — abandoned 28 Jul 2014. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number

85472773

Mark type

Design + words

Filed

15 Nov 2011

Published for opposition

30 Oct 2012

Abandoned

28 Jul 2014

Attorney of record

Karl M. Zielaznicki

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of hypertension, depression, cardiovascular disease, allergies, neurological disorders, gastro-intestinal disease, urinary incontinence, Parkinson's disease, Alzheimer's disease, oncology, diabetes and metabolic disorders, dermatological disorders, bipolar disorder and schizophrenia, vitamin D deficiency, bleeding disorders, BPH or benign prostatic hyperplasia, erectile dysfunction and pain, women's health issues relating to birth control, menstruation, menopause, breast health and disorders, sexual health and disorders, female reproductive health and disorders, pregnancy and autoimmune diseases

Owner

• Amerigen Pharmaceuticals, Ltd., KY1-1111, KY
• Amerigen Pharmaceuticals, Ltd., KY1-1111, KY

Prosecution history

• 28 Jul 2014 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
• 28 Jul 2014 — ABANDONMENT - NO USE STATEMENT FILED
• 04 Feb 2014 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 03 Feb 2014 — SOU EXTENSION 2 GRANTED
• 23 Dec 2013 — SOU EXTENSION 2 FILED
• 31 Jan 2014 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
• 23 Dec 2013 — SOU TEAS EXTENSION RECEIVED
• 15 May 2013 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 13 May 2013 — SOU EXTENSION 1 GRANTED
• 13 May 2013 — SOU EXTENSION 1 FILED
• 13 May 2013 — SOU TEAS EXTENSION RECEIVED
• 25 Dec 2012 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 30 Oct 2012 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 30 Oct 2012 — PUBLISHED FOR OPPOSITION
• 10 Oct 2012 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED